Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial

PaperCitations, authors & open-access status

Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 452 citations, 2016 year and green oa status.

452
Citations
2016
Year
green
OA Status

Related on ScholarIQ

Catherine Lubetzki
Author
The Lancet
Journal
Sphingolipid Metabolism and Signaling
Topic
Sphingolipid Metabolism and Signaling
Topic
Multiple Sclerosis Research Studies
Topic
Spondyloarthritis Studies and Treatments
Topic
470M+ articles · free account